Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all, empowering individuals with vital genetic insights and enabling healthcare providers to better detect, treat and prevent disease. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs.
Tempus is making precision medicine a reality through the power and promise of data and artificial intelligence. Tempus offers companion diagnostic development across our portfolio of assays, leveraging a broad-panel, a universal platform used by thousands of oncologists globally. These assays can each incorporate multiple companion diagnostic markers, providing value across biopharma portfolios
Promega provides a broad portfolio of functional bioassays, immunoassays and protein characterization tools to accelerate your biologics drug discovery and development. We offer state-of-the-art reporter and health assays for potency testing, tools for antibody purification and mass spec analysis and a suite of products for simple and fast analyte detection using our Lumit™ luminescence technology. All our products are developed and manufactured under rigorous quality standards and our bioassays are pre-qualified according to ICH guidelines. Learn more to help accelerate your research.
Eurofins Viracor Biopharma
Biopharma is a trusted provider of drug development testing solutions to pharmaceutical companies. We are a leader in bioassay development and testing for infectious diseases, vaccines, immunology, and oncology. For more than 35 years, we have been dedicated to helping clients through specialized clinical trial expertise, and high-quality, accurate results to evaluate the safety and efficacy of drug candidates. We offer broad experience in molecular/genomic testing, vaccine safety assessment, immunogenicity, and cell-based assays.
IntoDNA provides its proprietary STRIDE technology for highly sensitive, direct, in situ detection of DNA damage. STRIDE combined with comprehensive solutions and expertise supports groups that develop DDR targeted therapies. The technology can be applied to a variety of biological materials at any stage of the drug development pipeline to enrich biopharmaceutical research
BPS Bioscience’s purpose is to advance new scientific discoveries that lead to therapies by creating innovative solutions for research. Our focus areas are immunotherapy, epigenetics, coronavirus, CRISPR, cell signaling, and others, providing 4500+ high quality recombinant cell lines, lentiviruses, proteins and biochemical and cell-based assay kits. As a primary manufacturer, we can supply products in large-scale bulk quantities, as well as contract and custom manufacturing. Our biochemical and cell-based screening services are also available to accelerate your research.
ANGLE’s proven patent-protected platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost-effective, highly multiplexed analysis of nucleic acids and proteins.
ANGLE’s Parsortix PC1 Clinical system is cleared by the FDA for the capture and harvest of circulating tumor cells (CTCs) from metastatic breast cancer patient blood for subsequent, user-validated analysis and has a CE-IVD mark for the intended clinical use.
Beacon Targeted Therapies
We are a clinical trial and pipeline database solution designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth, and real-time information in the rapidly evolving drug development landscape. For more information or to request a demo, visit our website: